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Cytochrome P450-mediated detoxification is one of the most
important mechanisms involved in insecticide resistance. How-
ever, the molecular basis of this mechanism and the physiological
functions of P450s associated with insecticide resistance remain
largely unknown. Here, we exploited the functional genomics and
reverse genetic approaches to identify and characterize a P450
gene responsible for the majority of deltamethrin resistance
observed in the QTC279 strain of Tribolium castaneum. We used
recently completed whole-genome sequence of T. castaneum to
prepare custom microarrays and identified a P450 gene, CYP6BQ9,
which showed more than a 200-fold higher expression in the
deltamethrin-resistant QTC279 strain when compared with its ex-
pression in the deltamethrin-susceptible Lab-S strain. Functional
studies using both double-strand RNA (dsRNA)-mediated knock-
down in the expression of CYP6BQ9 and transgenic expression
of CYP6BQ9 in Drosophila melanogaster showed that CYP6BQ9
confers deltamethrin resistance. Furthermore, CYP6BQ9 enzyme
expressed in baculovirus metabolizes deltamethrin to 4-hydroxy
deltamethrin. Strikingly, we also found that unlike many P450
genes involved in insecticide resistance that were reported pre-
viously, CYP6BQ9 is predominantly expressed in the brain, a part
of the central nervous system (CNS) containing voltage-gated
sodium channels targeted by deltamethrin. Taken together, the
current studies on the brain-specific insect P450 involved in delta-
methrin resistance shed new light on the understanding of the
molecular basis and evolution of insecticide resistance.
functional genomics | insecticide resistance | RNA interference | transgenic
expression | insecticide metabolism
Understanding the molecular basis of resistance mechanisms,including discovering the function of resistance-related genes,
is critical to designing novel resistance management strategies
and developing new insecticidal compounds. With its whole-
genome sequencing completed, Tribolium castaneum has become
an idealmodel organism for researchon insecticide resistance (1, 2).
T. castaneum belongs to the most species-rich eukaryotic order
(Coleoptera), containing about 25% of animal species. It is a noto-
rious worldwide pest of stored grains and farinaceous materials
(3, 4), has developed resistance to all five classes of insecticides
and fumigants used against it, and ranks among the top 20 arthro-
pods in the number of cases of resistance development reported
(http://www.pesticideresistance.org/). Moreover, the functional ge-
nomics method, RNA interference (RNAi), works systemically in
any tissue and developmental stage of T. castaneum (5, 6).
Pyrethroid insecticides are one of the most widely used classes
of insecticides for the control of insect pests that feed on crops
and transmit diseases (7). However, pyrethroid resistance has
broadly developed in many insect pests (http://www.pesticidere-
sistance.org/). The most significant mechanisms involved in py-
rethroid resistance are increased metabolic detoxification by
cytochrome P450s (8–10) and decreased target-site sensitivity of
sodium channels (11). P450s constitute the largest gene super-
family and are found in a variety of organs and tissues of many
organisms (8). Insect P450s are known to play an important role
in detoxifying insecticides (8, 12) and plant toxins (13), resulting
in the development of resistance to insecticides and facilitating
the adaptation of insects to their plant hosts. An important
character of insect P450s that are involved in resistance is the
constitutively transcriptional overexpression in insecticide-
resistant strains, causing enhanced metabolic detoxification of
insecticides (8, 14). The insect voltage-gated sodium channel is
the primary target of pyrethroids and dichlorodiphenyltri-
chloroethane (DDT) (15). Mutations in sodium channels confer
pyrethroid resistance by reducing the binding of pyrethroids to
the sodium channel. The most common sodium channel muta-
tion (kdr, L to F/H/S) has been identified in many insects (16). In
addition, nine other amino acid mutations were also shown to
cause kdr and kdr-type resistance (11).
A T. castaneum strain, QTC279, exhibits high levels of re-
sistance to deltamethrin, a pyrethroid insecticide. This resistance
was almost completely suppressed by piperonyl butoxide (PBO),
an inhibitor of cytochrome P450s, suggesting that P450-mediated
detoxification is the major mechanism involved in deltamethrin
resistance in the QTC279 strain (3). The current studies were
conducted to test this hypothesis and identify P450s involved in
deltamethrin resistance of the QTC279 strain.
Results
Identification of Genes Differentially Expressed in Resistant and
Susceptible Strains. A T. castaneum custom microarray contain-
ing 15,008 probe sets (60-mer oligonucleotides) was hybridized
with probes prepared using total RNA samples isolated from the
QTC279 (deltamethrin resistant) and Lab-S (deltamethrin sus-
ceptible) adult beetles. The spot intensity data for these probe sets
were statistically analyzed using GeneSpring software (Agilent
Technologies). Fold differences in expression and the significance
of difference (P value) for 10,879 probe sets detected by at least
one of the six probes hybridized are shown as a volcano plot (Fig.
1A). Among the genes tested, 108 probe sets showed significant
differences in expression between QTC279 and Lab-S (P ≤ 0.001
and ≥ 2-fold differential expression). Of these 108 probe sets, 75
showed an increase and 33 showed a decrease in the QTC279
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strain when compared with their expression in the Lab-S strain.
To correct for occurrence of false positives, we introduced two
multiple-testing corrections to adjust P values. Benjamini and
Hochberg multiple-testing corrections with a false discovery rate
of 0.001 revealed 64 probe sets detected genes that are differen-
tially expressed between QTC279 and Lab-S. In QTC279 strain,
the signal intensities of 47 probe sets showed an increase and 17
probe sets showed a decrease when compared with their expres-
sion in the Lab-S strain. Among these 47 probe sets, eight hy-
bridized to genes that code for P450 enzymes and one hybridized
to a gene coding for GST. However, when we applied a more
stringent Bonferroni multiple-testing correction, only three probe
sets were identified with significantly different expression between
QTC279 and Lab-S. One of the three probe sets recognized
GLEAN_02938, which codes for a transcription factor similar to
a NFX-1-type zinc finger-containing protein (NFX-1). The NFX-
1 is conserved in both invertebrates and vertebrates, but the
function of this protein is not well known. The signal intensities
for this gene were >200-fold lower in the QTC279 strain com-
pared with the Lab-S strain. The other two probe sets recognized
GLEAN_07318 and GLEAN_07319, and showed >200-fold
higher signal intensities in the QTC279 strain compared with
the Lab-S strain. T. castaneum whole-genome sequencing and
gene prediction data (http://beetlebase.org/) showed that both
GLEAN_07318- and GLEAN_07319-predicted ORFs are lo-
cated adjacent to each other in chromosome LG4. Gene cloning,
sequence alignment (Fig. S1), and Northern hybridization (Fig.
S2) showed that these two ORFs predicted by the whole-genome
sequencing project are part of the same gene, CYP6BQ9, named
by the P450 nomenclature committee.
To validate differential expression of genes identified by
microarray analyses, quantitative real-time PCR (qRT-PCR) was
employed with primers (Table S1) designed based on sequences
of genes identified in microarray analyses. Twelve genes (in-
cluding seven genes coding for P450 enzymes, one gene each
coding for GST, oxidoreductase, a conserved hypothetical pro-
tein, a transcription factor, and a protein with unknown function)
identified by Benjamini and Hochberg false discovery rate mul-
tiple-testing correction applied to microarray data were selected
for qRT-PCR analysis. These genes were selected based on their
differential expression between the QTC279 and Lab-S strains as
well as their potential role in insecticide detoxification. The qRT-
PCR analysis confirmed data obtained by microarray analysis for
10 of 12 genes (Fig. 1B and Table S2). Six of the confirmed genes
code for P450 enzymes. The microarray data showed over-
expression of GSTΩ1 and CYP6BQ3P in the QTC279 strain, but
qRT-PCR analysis did not show such an increase in the QTC279
strain for these two genes. Based on the consistent data derived
from both microarray and qRT-PCR analyses, CYP6BQ9 showed
the most remarkable difference between the QTC279 and Lab-S
strains. Therefore, we hypothesized that the P450 gene,
CYP6BQ9, may play the most important role in the deltamethrin
resistance of the QTC279 strain.
To test our hypothesis, we quantified the expression level of
CYP6BQ9 (Fig. 1C) and deltamethrin resistance (Fig. 1D) in
QTC279, F1 (offspring of QTC279 male and Lab-S female), and
two susceptible T. castaneum strains, GA-2 and Lab-S. As shown
in Fig. 1 C and D, a positive correlation between relative ex-
pression levels of CYP6BQ9 and deltamethrin resistance was
observed among the tested strains of beetles. These data suggest
that the P450 gene, CYP6BQ9, plays an important role in
deltamethrin resistance.
RNAi Aided Suppression of Deltamethrin Resistance. To further in-
vestigate the function of CYP6BQ9, we employed RNAi tech-
nology to knock down the expression of CYP6BQ9 in the
QTC279 beetles. Our RNAi experiment showed that the
CYP6BQ9 mRNA levels decreased by >97% at 5 days after in-
jection of CYP6BQ9 dsRNA (Fig. 2A), indicating that this gene
was successfully silenced by RNAi.
To determine whether knocking down the expression of
CYP6BQ9 causes suppression of deltamethrin resistance in the
QTC279 strain, we performed bioassays to compare deltamethrin
resistance levels among uninjected QTC279 beetles and Lab-S
beetles and CYP6BQ9 ormalE dsRNA injected QTC279 beetles.
As shown in Fig. 2B, 0.1 mg/48 cm2 or higher concentrations of
deltamethrin caused 100% mortality in the Lab-S strain (n =
186; slope = 1.20 ± 0.17; LC50 = 0.02 mg/48 cm2 [95% CI =
0.01–0.02]). In contrast, 100% mortality was not achieved even
after treating the resistant QTC279 strain with 1,000 mg/48 cm2
deltamethrin (n = 68; slope = 0.50 ± 0.15; LC50 = 80.13 mg/48
cm2 [95% CI = 38.53–541.85]). The resistance ratio between the
QTC279 and Lab-S strains is 4,007. A similar dose response to
deltamethrin was observed in the QTC279 beetles injected with
malE dsRNA (n = 84; slope = 0.44 ± 0.12; LC50 = 46.02 mg/48
cm2 [95% CI = 23.62–167.91]; resistance ratio = 2,301). How-
ever, the QTC279 beetles injected with CYP6BQ9 dsRNA
showed a much higher susceptibility to deltamethrin (n = 78;
slope = 0.77 ± 0.19; LC50 = 0.79 mg/48 cm2 [95% CI = 0.37–
1.35]). As a result, the resistance ratio between the QTC279
strain injected with CYP6BQ9 dsRNA and the Lab-S strain
decreased dramatically (to <40). These data suggest that
Fig. 1. Differential expression of T. castaneum genes. (A) The V plot of
differentially expressed genes identified by microarray analysis. The P values
of t test were plotted against fold suppression or overexpression. The hori-
zontal bar in the plot shows the nominal significant level 0.001 for the t test
under the assumption that each gene had a unique variance. The vertical
bars separate the genes that are a minimum of 2.0-fold difference in the
QTC279 strain when compared with their levels in the Lab-S strain. Three
independent samples each containing 10 adult QTC279 or Lab-S beetles
were analyzed. The genes identified by the Bonferroni multiple-testing
correction are shown. (B) Correlation between microarray data and qRT-PCR
data of genes selected from the list shown in Table S2. Both microarray and
qRT-PCR data showed similar fold changes for most genes with only two
exceptions, GSTΩ and CYP6BQ3P. The genes were labeled with gene names
for those with identified gene products, and the rest of them were labeled
with Glean numbers. (C) Relative expression of CYP6BQ9 in QTC279, F1
(offspring of QTC279 male and Lab-S female), GA-2, and Lab-S strain. The
data shown are the mean + SEM (n = 4). (D) The resistant ratio of delta-
methrin in QTC279, F1 (offspring of QTC279 male and Lab-S female), GA-2,
and Lab-S strains. The resistance ratios were calculated by comparing LC50
values obtained with QTC279, F1 (offspring of QTC279 male and Lab-S fe-
male), and GA-2 with the LC50 obtained with Lab-S strain.
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CYP6BQ9 is required for the high level of deltamethrin re-
sistance observed in the QTC279 strain.
Brain-Specific Expression. Insect P450s are known to be expressed
in various tissues in response to diverse physiological and envi-
ronmental stimuli (8). Therefore, the expression of CYP6BQ9
was quantified in the ovary, midgut, fat body (thorax and abdo-
men), and brain (free from fat body and other tissues) isolated
from the QTC279 and Lab-S beetles. As shown in Fig. 3 A and B,
CYP6BQ9 mRNAs were detected predominantly in the brain of
both QTC279 and Lab-S strains. Because midgut and/or fat body
tissues were suggested as the primary detoxification organs
where most insect P450s are expected to be expressed (8), we
used transgenic Drosophila melanogaster to test whether the
predominant CYP6BQ9 expression in the CNS observed in our
studies is sufficient to cause deltamethrin resistance.
Transgenic Expression of CYP6BQ9 in D. melanogaster. To identify if
the expression of CYP6BQ9 is sufficient to cause deltamethrin
resistance, CYP6BQ9 was introduced into the vector pCaSpeR-
hs (under the control of the heat shock protein 70 promoter).
After embryonic microinjections of D. melanogaster w1118 with
pCaSpeR-hs-CYP6BQ9 (pCa-CYP6BQ9) plasmids, 20 lines of
flies, in which the expression of CYP6BQ9 could be enhanced
after heat shock, were identified. Two independent transformed
lines with homozygous CYP6BQ9 expression in the chromosome
III were chosen to perform contact bioassays and expression
studies. We quantified mRNA produced from the CYP6BQ9
transgene using qRT-PCR in two pCa-CYP6BQ9 transformed
lines. CYP6BQ9 mRNA was detected in both transformed lines,
and the expression was enhanced by heat shock in both lines
(Fig. 4A). In addition, the CYP6BQ9 mRNA was not detected in
three control D. melanogaster strains (yw1118, CNS-GAL4, and
Act5C-GAL4), which were not transformed with pCa-CYP6BQ9
construct (Fig. 4A). Bioassays showed that both transgenic lines
of flies transformed with pCa-CYP6BQ9 constructs were tolerant
to deltamethrin at a diagnostic dose of 10 μg deltamethrin per
vial with higher survival rates (around 40% at 25 °C and 80% at
37 °C) than the control flies (less than 10%; Fig. 4B). These
findings suggest that the expression of CYP6BQ9 alone is suffi-
cient to cause deltamethrin resistance.
Transgenic D. melanogaster were also produced to express
CYP6BQ9 in the CNS alone or in the whole body using the GAL4/
UAS system. We compared the expression of CYP6BQ9 in two
control strains and two strains expressing UAS-CYP6BQ9 under the
control of a CNS-GAL4 driver (CNS > CYP6BQ9) or an Act5C-
GAL4driver (Act5C>CYP6BQ9).As shown inFig. 4C, higher levels
of CYP6BQ9 mRNA were detected in the whole body of Act5C >
CYP6BQ9 transgenic flies when compared with its expression in the
whole-body samples of CNS > CYP6BQ9 flies. CYP6BQ9 was
expressed in all three tissues (midgut, fat body, and CNS) tested
in Act5C > CYP6BQ9 transgenic flies, whereas CYP6BQ9 was
expressed predominantly in the CNS but with low levels in both
midgut and fat body of CNS > CYP6BQ9 transgenic flies (Fig. 4 D
and E). In contact bioassays, 80% of both lines of transgenic flies
(Act5C>CYP6BQ9andCNS>CYP6BQ9) survived at a diagnostic
dose of 10 μg deltamethrin per vial (Fig. 4F). However, none of the
control flies survived this dose of deltamethrin (Fig. 4F). These data
suggest that the expression of CYP6BQ9 in the CNS is sufficient for
causing deltamethrin resistance.
Pyrethroid Metabolism. Experiments were conducted to deter-
mine whether CYP6BQ9 could metabolize deltamethrin. The
CYP6BQ9 protein was expressed in Sf9 insect cells using
a baculovirus expression system. To ensure an intact electron
supply, the P450 was coexpressed with a cytochrome P450 re-
ductase (CPR) from D. melanogaster (GenBank accession no.
Q27597). The recombinant CYP6BQ9 and CPR proteins effi-
ciently debenzylated the artificial model substrate, benzyloxy-
resorufin (resorufin benzyl ether, BOMR), to its red-fluorescent
product resorufin with a Km value of 4.8 ± 0.9 μM (Fig. 5A;
activity given in pmol/min per mg total protein) and a Vmax of
11.5 ± 0.5 mg/nmol per min protein. In control experiments, no
turnover was caused by proteins isolated from cells infected with
the baculovirus containing vector with no insert of CYP6BQ9.
More importantly, deltamethrin itself could be metabolized by
the recombinant CYP6BQ9/NADPH CPR microsomes in in
vitro assays. Samples from such metabolism experiments were
subjected to tandem mass spectrometry (HPLC-MS/MS). As
shown in Fig. 5B, only the CYP6BQ9 protein displayed in vitro
activity, and the control that used protein from cells infected
with the baculovirus vector without insert showed no activity.
Subsequently, the deltamethrin metabolite was identified as 4-
hydroxy deltamethrin (m/z 539.2) via HPLC-MS/MS measure-
ment (Fig. 5C). These experiments provided direct evidence for
CYP6BQ9 metabolizing deltamethrin, to which the QTC279
strain resists, thus further confirming the function of CYP6BQ9
in deltamethrin resistance of the QTC279 strain.
Discussion
In this study, we employed the recently completed genome se-
quence of T. castaneum and functional genomics methods to
Fig. 2. Knockdown in the expression of CYP6BQ9 in T. castaneum QTC279
strain reduced its resistance to deltamethrin. (A) The mRNA levels of
CYP6BQ9 were quantified by qRT-PCR at 5 days after dsRNA injection. The
relative mRNA levels were shown as a ratio in comparison with the levels of
rp49 mRNA. The data shown are mean + SEM (n = 3). Statistical significance
of the gene expression between two samples was calculated using Student’s
t test. **P < 0.01. (B) Dose-response curves (log dose versus mortality on
a probit scale) for T. castaneum adults exposed to deltamethrin. Bioassays
were performed 5 days after dsRNA injection. Lab-S (◯), a susceptible strain;
QTC279 (▽), a deltamethrin resistant strain; QTC279-CYP6BQ9 RNAi (●),
QTC279 strain injected with CYP6BQ9 dsRNA; and QTC279-malE RNAi (▼),
QTC279 strain injected with malE dsRNA as a control were exposed to var-
ious doses of deltamethrin, and the mortality was recorded and graphed.
Fig. 3. Tissue-specific expression of CYP6BQ9. Relative expression levels of
CYP6BQ9 in the ovary, midgut, fat body, and brain of the QTC279 (A) and
Lab-S (B) strains. Tissues were dissected and total RNAs were isolated to
quantify CYP6BQ9 mRNA levels by qRT-PCR as described in Materials and
Methods. Relative expression levels were normalized by the expression of
rp49. The data shown are mean + SEM (n = 9).
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uncover the molecular mechanisms of deltamethrin resistance in
T. castaneum QTC279 strain. Based on the data presented here,
we conclude that P450-mediated detoxification is the major
mechanism of resistance against the synthetic pyrethroid, delta-
methrin, in the QTC279 strain. We identified a P450 gene,
CYP6BQ9, which is responsible for the majority of pyrethroid
resistance observed in this strain. The most surprising finding was
the brain-specific expression of this deltamethrin-detoxifying
P450 gene, CYP6BQ9. Deltamethrin, like most other pyreth-
roids, is a lipophilic low-molecular-weight neurotoxin. It is ca-
pable of penetrating the blood-brain barrier and binding to
voltage-gated sodium channels (15). The high expression level of
CYP6BQ9 in the brain could greatly enhance the ability of brain
cells to metabolize the insecticide and thus significantly deplete
the levels of insecticide at the target site necessary for insect
control. CYP6D1, a house fly P450 responsible for pyrethroid
resistance in the LPR strain, was shown to metabolize pyreth-
roids in the thoracic ganglia (17). The authors suggested that the
expression of P450 in the nervous system might provide the last
line of defense to protect the target site. In vertebrates, many
P450 genes have been demonstrated to be present in the brain
(partially or predominantly), catalyzing the metabolism of neu-
rosteriods and drugs (18, 19). Drosophila P450 gene CYP4G15 is
primarily expressed in the brain of third instar, but there is no
evidence of its role in insecticide resistance (8, 20, 21). Our
studies make a causal connection between brain-specific ex-
pression of an insect P450 gene and its function in the de-
toxification of an insecticide. Because most of the insecticides
are neurotoxins, the central nervous system—especially the brain
—could be considered as a target tissue to identify more insect
P450s that are involved in insecticide resistance.
Cytochrome P450s are an abundant family of metabolic
enzymes found in all living organisms (8). Previous studies sug-
gested that multiple P450s commonly share the role associated
with insecticide resistance through coup regulation in resistant
strains. For example, CYP6G1 and CYP12D1 are overexpressed
in DDT-resistant strains of D. melanogaster (22). In a permeth-
rin-resistant housefly strain ALHF, CYP4D4v2, CYP4G2,
CYP6A38, and CYP6A36 are up-regulated through induction
(23) or constitutive expression (14). The overexpression of two
Fig. 4. The expression of T. castaneum CYP6BQ9 and its effect on deltamethrin resistance in D. melanogaster. (A) The mRNA levels of CYP6BQ9 were
quantified by qRT-PCR in three control nontransgenic strains (yw1118, CNS-GAL4, and Act5C-GAL4) and two different transgenic fly lines (pCa-CYP6BQ9 13 and
pCa-CYP6BQ9 23; both of them showed CYP6BQ9 insertion in the third chromosome). The expression levels of CYP6BQ9 in both transformed lines were
enhanced by heat shock. The data shown are the mean + SEM (n = 4). (B) The percent survival of three control nontransgenic strains and two different
transgenic fly lines exposed to 10 μg deltamethrin/vial at 25 °C and 37 °C. The data shown are mean + SEM (n = 5). The data (A and B) were analyzed by
ANOVA, followed by Bonferroni multiple mean separation techniques at P < 0.05 (SAS v9.0 software; SAS Institute Inc.). There is no significant difference in
the level of expression among samples marked with the same letter. (C) The relative expression of CYP6BQ9 in two control strains (CNS-GAL4 and Act5C-
GAL4) and two transgenic lines (CNS > CYP6BQ9 and Act5C > CYP6BQ9) are shown. The data shown are mean + SEM (n = 4). (D and E) Tissue-specific ex-
pression of CYP6BQ9 in CNS > CYP6BQ9 and Act5C > CYP6BQ9 strains, respectively. Relative expression levels were normalized using rp49 expression as
a control. The data shown are mean + SEM (n = 4). (F) The percent survival of two control strains and two transgenic lines exposed to 10 μg deltamethrin/vial.
The data shown are mean + SEM (n = 8).
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duplicated P450s, CYP6P4 and CYP6P9, is associated with py-
rethroid resistance in A. funestus strains (10). Our microarray
and qRT-PCR data identified several genes that are up-regu-
lated in the QTC279 strain. Although our data suggest that
CYP6BQ9 may play a major role in deltamethrin resistance in
the QTC279 strain, the contribution from other genes to delta-
methrin resistance cannot be ruled out. Because dsRNA-aided
knockdown in the expression of CYP6BQ9 did not completely
block deltamethrin resistance in the QTC279 strain, we hy-
pothesize that one or more of the other overexpressed genes in
the QTC279 strain may play minor roles in deltamethrin re-
sistance. Experiments to test this hypothesis are currently un-
derway. CYP6BQ9 is a member of a 12-P450 gene cluster, and
two other members of this cluster are also overexpressed in the
QTC279 strain. Work is in progress to determine the role of
these two P450s in deltamethrin resistance of the QTC279 strain.
Transgenic overexpression of P450s in D. melanogaster was
successfully exploited to evaluate the function of fruit fly P450s
in insecticide resistance. The GAL4/UAS system has been used
to express CYP6G1 in all tissues (24) or in specific tissues (25),
and the expression of this gene in transgenic fruit flies conferred
resistance to insecticides tested. The CYP12A4 expressed spe-
cifically in the midgut and Malpighian tubules of D. melanogaster
conferred resistance to the insecticide lufenuron (26). In another
study, eight D. melanogaster P450s were expressed in the midgut,
Malpighian tubules, and fat body, and some of them conferred
resistance to multiple insecticides (27). In the present study,
a T. castaneum P450 expressed ubiquitously or in the CNS of
D. melanogaster conferred resistance to deltamethrin. Though
the P450 sequences are highly divergent across the taxa, the CPR
and cytochrome b5 sequences remain more evolutionary con-
served (28). Taken together, these studies suggest that the power
of genetics and genomics in fruit flies could be exploited for
studying the function of P450s from pest insects.
Our studies showed that the brain-specific overexpression of
one P450 gene is responsible for the majority of deltamethrin
resistance observed in the QTC279 strain, but the mechanism of
the overexpression of CYP6BQ9 in the QTC279 strain is not
known. Microarray and qRT-PCR analyses showed that the ex-
pression of a transcription factor, NFX-1, was reduced in the
QTC279 strain when compared with its expression in the Lab-S
strain (Table S2). However, RNAi-aided knockdown in the ex-
pression of NFX-1 in the Lab-S strain (Fig. S3A) neither affected
deltamethrin susceptibility (Fig. S3B) nor caused an increase in
the expression of CYP6BQ9 (Fig. S3C). Combined with the lack
of positive correlation between expression of NFX-1 and delta-
methrin resistance (Fig. S3D) and tissue-specific expression of
NFX-1 (Fig. S3E), we concluded that NFX-1 may not play an
important role in the regulation of CYP6BQ9 expression in
T. castaneum. We hypothesize that either the differences in cis-
regulatory elements present in the promoters of CYP6BQ9 from
the QTC279 and Lab-S strains and/or the expression of tran-
scription factors that bind to these elements may be responsible
for enhanced expression of CYP6BQ9 in the QTC279 strain.
Work is in progress to elucidate the mechanism of CYP6BQ9
expression in the QTC279 strain of T. castaneum.
Materials and Methods
Red Flour Beetle Strains. Three red flour beetle strains were used in this study.
QTC279, originally collected from a wheat storage facility in Malu, Queens-
land, Australia, in 1984, was selectedwith pyrethroids for 10 generations until
it was homozygous for the major pyrethroid resistance factor (3). Lab-S is
a laboratory strain that is susceptible to most of the insecticides tested. GA-2
was used in the whole-genome sequencing project. Beetles were reared in
Fig. 5. The metabolic activity of recombinant
CYP6BQ9enzyme. (A) Rateofdealkylation reactionof
recombinant CYP6BQ9with thefluorescent substrate
BOMR (Vivid; Invitrogen). The Km value was de-
termined as 4.8 ± 0.9 μM. (B) In vitro activity assays
with recombinant CYP6BQ9. Microsomes from Sf9
cells expressing QTC279 CYP6BQ9 and D. mela-
nogaster CPRwere incubatedwith deltamethrin for 3
h followedbymass spectrometric analyses. The empty
baculovirus vector containing cells were used as
a control. Thepeakareaof themajormetabolite (+16)
was quantified. The data shown are mean + SEM (n =
3). (C) Mass spectrum of 4-hydroxy deltamethrin, the
only metabolite detected in in vitro experiments in-
cubating deltamethrin and CYP6BQ9 reconstituted
protein complex.
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whole wheat flour with yeast (10% by weight) and maintained in the dark
at 32 °C and 55 ± 2% relative humidity.
RNA Extraction, Analyses, and RNAi. Standard procedures as described in SI
Materials and Methodswere used to prepare RNA and probes for microarray
analysis. Three biological replicates were included for each sample analyzed.
The 60-mer oligonucleotides designed based on 15,008 genes selected from
the 16,000 genes predicted by Tribolium genome annotations and 736 control
probe sets were printed onto glass slides at Agilent Technologies. Probes for
microarray analysis were labeled using Low RNA Input Linear Amplification
Kit with one color (Agilent) following manufacturer’s instructions. The hy-
bridization of labeled probes to arrays was performed using the Agilent Gene
Expression Hybridization Kit at 65 °C for 17 h. The raw data files (.txt) were
imported into GeneSpring (GX 7.3), and the data were normalized and ana-
lyzed. Further details onmicroarray methods can be found in SI Materials and
Methods. qRT-PCR and Northern blot analysis were performed following
standard procedures as described in SI Materials and Methods. For RNAi
experiments, dsRNAs were synthesized using the MEGAscript RNAi Kit
(Ambion, Inc.) and 300- to 400-bp-long PCR-amplified DNA from unique
regions of genes using gene-specific primers containing T7 promoter at the
end. One- to 2-week-old adults were injected with dsRNA (0.8–1 μg). Further
details on RNAi methods can be found in SI Materials and Methods.
Tribolium Bioassays. Beetles were exposed to filter paper surface treated with
serial dilutions of technical grade deltamethrin (Bayer Environmental Sci-
ence) prepared in ethanol. Beetle mortality was scored after 24-h exposure in
the dark at 32 °C and 55 ± 2% relative humidity. Mean and standard errors
for each time point were obtained from at least three independent bio-
assays. All data were analyzed by using MINITAB statistical software (MINI-
TAB 14; Minitab, Inc.).
Construction of Transgenic Fly Strains and Drosophila Contact Bioassays.
CYP6BQ9 cloned from the QTC279 strain was inserted into pCaSpeR-hs
and pUAST vectors to prepare pCa-CYP6BQ9 and UAS-CYP6BQ9 constructs,
and the constructs were transformed into the germline of D. melanogaster
yw1118 strain using standard P-element-mediated transformation techniques
(29). The transgenic flies were assayed for deltamethrin susceptibility as
described in SI Materials and Methods.
BOMR Metabolism. BOMR metabolism by CYP6BQ9 microsomes was carried
out in a 384-well plate as described in the Vivid CYP450 screening kit (Invi-
trogen) manual with the prepared microsomes of CYP6BQ9/NADPH CPR (0.1
mg/mL protein content) and 0.1–50 μM benzyloxyresorufin substrate and an
assay volume of 50 μL. Fluorescence was detected upon incubation for 60
min at 22 °C on a Tecan Infinite M1000 fluorescence reader (λex = 535 nm,
λem = 590 nm, 10 nm bandwidth), revealing an apparent Km of 4.8 ± 0.9 μM.
Deltamethrin Metabolism. Deltamethrin metabolism was assayed by incuba-
tion of the recombinant CYP6BQ9/NADPH CPR microsomes (0.2 mg/mL total
protein content) in 0.1 M potassium phosphate buffer with NADPH-regener-
ating system (Promega; 1.3 mMNADP+, 3.3 mMglucose-6-phosphate, 3.3 mM
MgCl2, 0.4 U/mL glucose-6-phosphate dehydrogenase) and deltamethrin
(10 μM) at 27 °C for 3 h. The total assay volume was 200 μL. The assay was
quenched by the addition of acetonitrile (to 80% final concentration) and
analyzed by tandem mass spectrometry.
Quantitative HPLC-MS/MS Measurements. The samples were measured on an
Applied Biosystems API 4000 QTrap MS/MS system running in positive elec-
trospray MRM mode with a capillary voltage of 5 kV and Turbo V gas
temperature of 500 °C. The HPLC system was a Waters Acquity UPLC con-
sisting of binary solvent manager, column manager, and sample manager.
The samples were run on a Waters Atlantis HSS T3 1.8-μm column (50 × 2.1
mm) running in reversed-phase gradient mode with methanol/2 mM
NH4OAc/1% acetic acid as eluent. For the quantification of deltamethrin and
4-OH deltamethrin, the MRM transition 523.0 > 280.9 and 539.0 > 280.9 was
monitored, respectively. The peak integrals were calibrated externally
against a standard calibration curve with a correlation coefficient of r > 0.99.
The limit of quantification (S/n > 10) was 0.1 ng/mL for deltamethrin.
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